Plant Comparison
Bitter Melon vs Milk Thistle
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Bitter Melon and Milk Thistle: they share 8 indicated uses (arthritis / joint pain, bloating, blood sugar / diabetes support, …); 5 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Bitter Melon | Milk Thistle | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Bloating | 1/10 | 5/10 | Stronger for Milk Thistle |
| Blood sugar / diabetes support | 9/10 | 7/10 | Stronger for Bitter Melon |
| Cancer (anticancer research) | 9/10 | 7/10 | Stronger for Bitter Melon |
| Indigestion | 1/10 | 5/10 | Stronger for Milk Thistle |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Milk Thistle |
| Metabolic support | 5/10 | 7/10 | Stronger for Milk Thistle |
| Skin irritation | 1/10 | 5/10 | Stronger for Milk Thistle |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
Pharmacological Actions
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c
Anti-inflammatory and antioxidant; Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic)
Digestive support / mild dyspepsia (traditional)
Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD); Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)
Traditional & Indicated Uses
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Improves glycemic control in type 2 diabetes - lowers fasting blood glucose and HbA1c
inferred from anticancer action
Supports liver recovery and 'detox' (traditional framing of the hepatoprotective action)
Digestive support / mild dyspepsia (traditional)
inferred from anti-inflammatory action
Hepatoprotective / liver support (protects liver cells, antioxidant and antifibrotic); May improve liver enzymes and hepatic fat in non-alcoholic fatty liver disease (NAFLD)
inferred from antidiabetic action
Safety, Cautions & Contraindications
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
Very well tolerated, even at high doses; the main effects are mild gastrointestinal upset (nausea, loose stools). As a member of the daisy family (Asteraceae), it can cause allergic reactions in sensitive people.
Has a low potential for drug interactions (little effect on liver CYP enzymes), but use caution with medicines that have a narrow therapeutic window. Human pregnancy data are limited, so use cautiously.
External Ids
Botanical Description
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Robust biennial (occasionally annual) thistle (Asteraceae), 30-150 cm tall. Leaves are glossy dark green with distinctive white marbled veining (the 'milk' of legend), spiny-margined and deeply lobed. Large, solitary, purple-pink thistle-type flower heads are surrounded by spiny bracts, followed by shiny, mottled brown-black seeds - the part used.[12]
Habitat
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Native to the Mediterranean region, now naturalised worldwide on disturbed, sunny ground - roadsides, waste places and dry pastures - and widely cultivated commercially for its seed.[12]
Harvesting
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Seed heads are harvested once fully dry (late summer), and the seeds (fruit) are threshed out.[12]
Traditional Uses
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Milk thistle has a very long European folk-medicine tradition, documented since antiquity, as a liver tonic, and its seed extract, standardised to the flavonolignan complex silymarin, is one of the most extensively studied herbal hepatoprotectants. Modern research supports antioxidant, anti-inflammatory and liver-protective activity, with growing interest in metabolic/blood-sugar effects.[12, 13]
Preparations
Dosage
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
References & Sources
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
- Abenavoli, L., Izzo, A.A., Milic, N., Cicala, C., Santini, A. and Capasso, R (2018) 'Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases', Phytotherapy Research, 32(11), pp. 2202-2213. doi:10.1002/ptr.6171 Meta-analysis / review
https://doi.org/10.1002/ptr.6171 - Bahmani, M., Shirzad, H., Rafieian, S. and Rafieian-Kopaei, M (2015) 'Silybum marianum: Beyond Hepatoprotection', Journal of Evidence-Based Complementary & Alternative Medicine, 20(4), pp. 292-301. doi:10.1177/2156587215571116 Meta-analysis / review
https://doi.org/10.1177/2156587215571116 - Wang, X., Zhang, Z. and Wu, S (2020) 'Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications', Journal of Agricultural and Food Chemistry, 68(42), pp. 11644-11664. doi:10.1021/acs.jafc.0c04791 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.0c04791 - Marmouzi, I., Bouyahya, A., Ezzat, S.M., El Jemli, M. and Kharbach, M (2020) 'The food plant Silybum marianum (L.) Gaertn.: Phytochemistry, Ethnopharmacology and clinical evidence', Journal of Ethnopharmacology, 265, pp. 113303. doi:10.1016/j.jep.2020.113303 Meta-analysis / review
https://doi.org/10.1016/j.jep.2020.113303 - Greenlee, H., Abascal, K., Yarnell, E. and Ladas, E (2007) 'Clinical applications of Silybum marianum in oncology', Integrative Cancer Therapies, 6(2), pp. 158-165. doi:10.1177/1534735407301727 Meta-analysis / review
https://doi.org/10.1177/1534735407301727 - Shaker, E., Mahmoud, H. and Mnaa, S (2009) 'Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage', Food and Chemical Toxicology, 48(3), pp. 803-806. doi:10.1016/j.fct.2009.12.011 Preclinical
https://doi.org/10.1016/j.fct.2009.12.011 - Flora, K., Hahn, M., Rosen, H. and Benner, K (1998) 'Milk thistle (Silybum marianum) for the therapy of liver disease', American Journal of Gastroenterology, 93(2), pp. 139-143. doi:10.1111/j.1572-0241.1998.00139.x Meta-analysis / review
https://doi.org/10.1111/j.1572-0241.1998.00139.x - Csupor, D., Csorba, A. and Hohmann, J (2016) 'Recent advances in the analysis of flavonolignans of Silybum marianum', Journal of Pharmaceutical and Biomedical Analysis, 130, pp. 301-317. doi:10.1016/j.jpba.2016.05.034 Meta-analysis / review
https://doi.org/10.1016/j.jpba.2016.05.034 - Ball, K.R. and Kowdley, K.V (2005) 'A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease', Journal of Clinical Gastroenterology, 39(6), pp. 520-528. doi:10.1097/01.mcg.0000165668.79530.a0 Meta-analysis / review
https://doi.org/10.1097/01.mcg.0000165668.79530.a0 - Tajmohammadi, A., Razavi, B.M. and Hosseinzadeh, H (2018) 'Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review', Phytotherapy Research, 32(10), pp. 1933-1949. doi:10.1002/ptr.6153 Meta-analysis / review
https://doi.org/10.1002/ptr.6153 - Ghahfarrokhi, S.H., Heidari-Soureshjani, S., Sherwin, C.M.T. and Azadegan-Dehkordi, Z (2024) 'Efficacy and Mechanisms of Silybum marianum, Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review', Current Rheumatology Reviews, 20(4), pp. 414-425. doi:10.2174/0115733971266397231122080247 Meta-analysis / review
https://doi.org/10.2174/0115733971266397231122080247 - Soleimani, V., Delghandi, P.S., Moallem, S.A. and Karimi, G (2019) 'Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review', Phytotherapy Research. doi:10.1002/ptr.6361 Randomized trial
https://doi.org/10.1002/ptr.6361 - Fallah, M., Davoodvandi, A., Nikmanzar, S., Aghili, S., Mirazimi, S.M.A., Aschner, M., Rashidian, A., Hamblin, M.R., Chamanara, M., Naghsh, N. and Mirzaei, H (2021) 'Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2021.112024 Preclinical
https://doi.org/10.1016/j.biopha.2021.112024 - Voroneanu, L., Nistor, I., Dumea, R., Apetrii, M. and Covic, A (2016) 'Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Journal of Diabetes Research. doi:10.1155/2016/5147468 Meta-analysis / review
https://doi.org/10.1155/2016/5147468 - Zhou, J., Chen, Y., Yu, J., Li, T., Lu, Z., Chen, Y., Zhang, X. and Ye, F (2021) 'The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials', Medicine (Baltimore), 100(12). doi:10.1097/MD.0000000000024884 Meta-analysis / review
https://doi.org/10.1097/MD.0000000000024884 - Fuhr, U., Beckmann-Knopp, S., Jetter, A., Lueck, H. and Mengs, U (2007) 'The effect of silymarin on oral nifedipine pharmacokinetics', Planta Medica, 73(14), pp. 1429-1435. doi:10.1055/s-2007-990256 Randomized trial
https://doi.org/10.1055/s-2007-990256 - Hadi, A., Pourmasoumi, M., Mohammadi, H., Symonds, M. and Miraghajani, M (2018) 'The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials', Complementary Therapies in Medicine, 41, pp. 311-319. doi:10.1016/j.ctim.2018.08.010 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2018.08.010
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.